The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Selenocyanatopropyl 2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetate ID: ALA4875617
PubChem CID: 164626525
Max Phase: Preclinical
Molecular Formula: C21H26N2O3Se
Molecular Weight: 433.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)OCCC[Se]C#N)OCC3
Standard InChI: InChI=1S/C21H26N2O3Se/c1-3-15-7-5-8-16-17-9-11-26-21(4-2,20(17)23-19(15)16)13-18(24)25-10-6-12-27-14-22/h5,7-8,23H,3-4,6,9-13H2,1-2H3
Standard InChI Key: ZNNJSDKTICYYLQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
16.6699 -14.7755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3798 -15.1841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3787 -14.3650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6949 -15.6275 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7353 -16.4401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4617 -16.8152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1100 -15.5526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1502 -16.3679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8729 -15.2626 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3847 -15.8985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9352 -16.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3001 -17.3067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1142 -17.3546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5621 -16.6691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1947 -15.9444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6419 -15.2604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4578 -15.3058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0916 -13.9583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8034 -14.3669 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.0916 -13.1370 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.5153 -13.9583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2271 -14.3669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9348 -13.9583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6466 -14.3669 0.0000 Se 0 0 0 0 0 2 0 0 0 0 0 0
22.3585 -13.9583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0668 -13.5423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6688 -13.9583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
2 4 1 0
2 7 1 0
4 5 1 0
5 6 1 0
6 8 1 0
7 8 2 0
8 11 1 0
10 9 1 0
9 7 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
15 16 1 0
16 17 1 0
3 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 3 0
1 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 433.41Molecular Weight (Monoisotopic): 434.1109AlogP: ┄#Rotatable Bonds: ┄Polar Surface Area: ┄Molecular Species: ┄HBA: ┄HBD: ┄#RO5 Violations: ┄HBA (Lipinski): ┄HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: ┄CX LogD: ┄Aromatic Rings: ┄Heavy Atoms: ┄QED Weighted: ┄Np Likeness Score: ┄
References 1. He X, Nie Y, Zhong M, Li S, Li X, Guo Y, Liu Z, Gao Y, Ding F, Wen D, Zhang Y.. (2021) New organoselenides (NSAIDs-Se derivatives) as potential anticancer agents: Synthesis, biological evaluation and in silico calculations., 218 [PMID:33799070 ] [10.1016/j.ejmech.2021.113384 ]